{"name":"SUN PHARM","slug":"sun-pharm","ticker":"","exchange":"","domain":"sunpharm.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharmaceuticals","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":3100000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[{"name":"Leqselvi","genericName":"DEURUXOLITINIB","slug":"deuruxolitinib","revenue":2600000000,"yoyGrowth":0,"percentOfTotal":83.9},{"name":"Sunpg 1622","genericName":"TILDRAKIZUMAB","slug":"tildrakizumab","revenue":500000000,"yoyGrowth":0,"percentOfTotal":16.1}],"timeline":[{"date":"1974-01-01","label":"Halog first approved","drug":"Halog","drugSlug":"halcinonide","type":"approval","sentiment":"positive"},{"date":"1978-01-01","label":"Westcort first approved","drug":"Westcort","drugSlug":"hydrocortisone-valerate","type":"approval","sentiment":"positive"},{"date":"1985-01-01","label":"Lac-Hydrin first approved","drug":"Lac-Hydrin","drugSlug":"ammonium-lactate","type":"approval","sentiment":"positive"},{"date":"1999-01-01","label":"Levulan first approved","drug":"Levulan","drugSlug":"aminolevulinic-acid","type":"approval","sentiment":"positive"},{"date":"2005-01-01","label":"Qualaquin first approved","drug":"Qualaquin","drugSlug":"quinine","type":"approval","sentiment":"positive"},{"date":"2006-01-01","label":"Dacogen first approved","drug":"Dacogen","drugSlug":"decitabine","type":"approval","sentiment":"positive"},{"date":"2018-01-01","label":"Sunpg 1622 first approved","drug":"Sunpg 1622","drugSlug":"tildrakizumab","type":"approval","sentiment":"positive"},{"date":"2020-01-01","label":"Winlevi first approved","drug":"Winlevi","drugSlug":"clascoterone","type":"approval","sentiment":"positive"},{"date":"2024-01-01","label":"Leqselvi first approved","drug":"Leqselvi","drugSlug":"deuruxolitinib","type":"approval","sentiment":"positive"},{"date":"2024-01-01","label":"Octreoscan first approved","drug":"Octreoscan","drugSlug":"pentetreotide","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-02-01","label":"ILUMYA Phase 3 readout (Moderate to Severe Genital Psoriasis)","drug":"ILUMYA","drugSlug":"tildrakizumab-asmn","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2029-04-01","label":"ILUMYA Phase 3 readout (Psoriatic Arthritis)","drug":"ILUMYA","drugSlug":"tildrakizumab-asmn","type":"phase3_readout","sentiment":"neutral"},{"date":"2031-08-05","label":"ILUMYA Phase 2 readout (Moderate-to-severe Chronic Plaque Psoriasis)","drug":"ILUMYA","drugSlug":"tildrakizumab-asmn","type":"phase3_readout","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":2600000000,"percentOfTotal":83.9,"drugCount":93,"colorKey":"oncology","drugs":[{"name":"Leqselvi","genericName":"DEURUXOLITINIB","slug":"deuruxolitinib","indication":"severe alopecia areata","status":"marketed","revenue":2600000000},{"name":"CABTREO Topical Gel","genericName":"CABTREO Topical Gel","slug":"cabtreo-topical-gel","indication":"Other","status":"phase_1"},{"name":"Ovide (malathion) lotion 0.05%","genericName":"Ovide (malathion) lotion 0.05%","slug":"ovide-malathion-lotion-0-05","indication":"Treatment of head lice infestations","status":"phase_3"},{"name":"Oxiconazole Nitrate Cream 1%","genericName":"Oxiconazole Nitrate Cream 1%","slug":"oxiconazole-nitrate-cream-1","indication":"Other","status":"phase_1"},{"name":"Protopic - Tacrolimus 0.1%","genericName":"Protopic - Tacrolimus 0.1%","slug":"protopic-tacrolimus-0-1","indication":"Other","status":"phase_1"},{"name":"SPARC1102 III","genericName":"SPARC1102 III","slug":"sparc1102-iii","indication":"Other","status":"phase_2"},{"name":"SUNPG1623 IV","genericName":"SUNPG1623 IV","slug":"sunpg1623-iv","indication":"Other","status":"phase_2"},{"name":"Aldara - Imiquimod 5%","genericName":"Aldara - Imiquimod 5%","slug":"aldara-imiquimod-5","indication":"Other","status":"phase_1"},{"name":"CLPG Topical Gel 1%","genericName":"CLPG Topical Gel 1%","slug":"clpg-topical-gel-1","indication":"Other","status":"phase_1"},{"name":"Clindamycin Phosphate RLD","genericName":"Clindamycin Phosphate RLD","slug":"clindamycin-phosphate-rld","indication":"Other","status":"phase_1"},{"name":"Desoximetasone 0.05% once daily","genericName":"Desoximetasone 0.05% once daily","slug":"desoximetasone-0-05-once-daily","indication":"Other","status":"phase_2"},{"name":"Desoximetasone 0.05% twice daily","genericName":"Desoximetasone 0.05% twice daily","slug":"desoximetasone-0-05-twice-daily","indication":"Other","status":"phase_2"},{"name":"Desoximetasone 0.25% once daily","genericName":"Desoximetasone 0.25% once daily","slug":"desoximetasone-0-25-once-daily","indication":"Other","status":"phase_2"},{"name":"Imiquimod 5% manufactured by Taro","genericName":"Imiquimod 5% manufactured by Taro","slug":"imiquimod-5-manufactured-by-taro","indication":"Other","status":"phase_1"},{"name":"Imiquimod Topical Cream 3.75%","genericName":"Imiquimod Topical Cream 3.75%","slug":"imiquimod-topical-cream-3-75","indication":"Other","status":"phase_1"},{"name":"Malathion gel 0.5%","genericName":"Malathion gel 0.5%","slug":"malathion-gel-0-5","indication":"Head lice infestation (pediculosis capitis)","status":"phase_3"},{"name":"Malathion lotion 0.5%","genericName":"Malathion lotion 0.5%","slug":"malathion-lotion-0-5","indication":"Other","status":"phase_1"},{"name":"NVXT Solution","genericName":"NVXT Solution","slug":"nvxt-solution","indication":"Other","status":"phase_2"},{"name":"Naftin® Gel 2%","genericName":"Naftin® Gel 2%","slug":"naftin-gel-2","indication":"Other","status":"phase_1"},{"name":"Oxymetazoline hydrochloride Cream, 1%","genericName":"Oxymetazoline hydrochloride Cream, 1%","slug":"oxymetazoline-hydrochloride-cream-1","indication":"Other","status":"phase_1"},{"name":"RETIN-A® Cream","genericName":"RETIN-A® Cream","slug":"retin-a-cream","indication":"Other","status":"phase_1"},{"name":"Ruxolitinib Topical Cream 1.5%","genericName":"Ruxolitinib Topical Cream 1.5%","slug":"ruxolitinib-topical-cream-1-5","indication":"Other","status":"phase_1"},{"name":"Tacrolimus 0.1% manufactured by Taro","genericName":"Tacrolimus 0.1% manufactured by Taro","slug":"tacrolimus-0-1-manufactured-by-taro","indication":"Other","status":"phase_1"},{"name":"Bactroban® Cream","genericName":"Bactroban® Cream","slug":"bactroban-cream","indication":"Other","status":"phase_1"},{"name":"Butenafine Hydrochloride Cream, 1%","genericName":"Butenafine Hydrochloride Cream, 1%","slug":"butenafine-hydrochloride-cream-1","indication":"Other","status":"phase_1"},{"name":"DPSG 7.5%","genericName":"DPSG 7.5%","slug":"dpsg-7-5","indication":"Other","status":"phase_1"},{"name":"DSXS1411","genericName":"DSXS1411","slug":"dsxs1411","indication":"Other","status":"phase_2"},{"name":"Duac® Topical Gel","genericName":"Duac® Topical Gel","slug":"duac-topical-gel","indication":"Other","status":"phase_1"},{"name":"GL0034 Dose Level 2","genericName":"GL0034 Dose Level 2","slug":"gl0034-dose-level-2","indication":"Other","status":"phase_2"},{"name":"GL0034 Dose Level 4","genericName":"GL0034 Dose Level 4","slug":"gl0034-dose-level-4","indication":"Other","status":"phase_2"},{"name":"Lotrimin Ultra®","genericName":"Lotrimin Ultra®","slug":"lotrimin-ultra","indication":"Tinea pedis (athlete's foot)","status":"marketed"},{"name":"Metronidazole Topical Gel 1%","genericName":"Metronidazole Topical Gel 1%","slug":"metronidazole-topical-gel-1","indication":"Other","status":"phase_1"},{"name":"NVXT topical","genericName":"NVXT topical","slug":"nvxt-topical","indication":"Other","status":"phase_2"},{"name":"Permethrin 1% rinse","genericName":"Permethrin 1% rinse","slug":"permethrin-1-rinse","indication":"Treatment and prevention of head lice infestations","status":"phase_3"},{"name":"Placebo topical cream","genericName":"Placebo topical cream","slug":"placebo-topical-cream","indication":"Other","status":"marketed"},{"name":"SCD-044_Dose 1","genericName":"SCD-044_Dose 1","slug":"scd-044-dose-1","indication":"Other","status":"phase_2"},{"name":"SPARC1023 I","genericName":"SPARC1023 I","slug":"sparc1023-i","indication":"Other","status":"phase_1"},{"name":"SPARC1028","genericName":"SPARC1028","slug":"sparc1028","indication":"Other","status":"phase_1"},{"name":"SPARC1104 modified dose regimen II","genericName":"SPARC1104 modified dose regimen II","slug":"sparc1104-modified-dose-regimen-ii","indication":"Undisclosed indication","status":"phase_3"},{"name":"SPARC1310 II","genericName":"SPARC1310 II","slug":"sparc1310-ii","indication":"Other","status":"phase_2"},{"name":"SPARC147609","genericName":"SPARC147609","slug":"sparc147609","indication":"Other","status":"phase_1"},{"name":"TA103","genericName":"TA103","slug":"ta103","indication":"Other","status":"phase_1"},{"name":"Topical TA-102 D","genericName":"Topical TA-102 D","slug":"topical-ta-102-d","indication":"Other","status":"phase_1"},{"name":"Tretinoin Gel Microsphere, 0.04%","genericName":"Tretinoin Gel Microsphere, 0.04%","slug":"tretinoin-gel-microsphere-0-04","indication":"Other","status":"phase_1"},{"name":"Tretinoin Gel Microsphere, 0.1%","genericName":"Tretinoin Gel Microsphere, 0.1%","slug":"tretinoin-gel-microsphere-0-1","indication":"Other","status":"phase_1"},{"name":"abiraterone acetate with Methylprednisolone","genericName":"abiraterone acetate with Methylprednisolone","slug":"abiraterone-acetate-with-methylprednisolone","indication":"Other","status":"phase_2"},{"name":"Azelaic Acid 15% topical gel","genericName":"Azelaic Acid 15% topical gel","slug":"azelaic-acid-15-topical-gel","indication":"Other","status":"phase_1"},{"name":"BenzaClin® Topical Gel","genericName":"BenzaClin® Topical Gel","slug":"benzaclin-topical-gel","indication":"Other","status":"phase_1"},{"name":"Bromday™","genericName":"Bromday™","slug":"bromday","indication":"Other","status":"marketed"},{"name":"Butenafine cream 1% manufactured by Taro","genericName":"Butenafine cream 1% manufactured by Taro","slug":"butenafine-cream-1-manufactured-by-taro","indication":"Other","status":"phase_1"},{"name":"Clindamycin and Benzoyl Peroxide Gel 1%5%","genericName":"Clindamycin and Benzoyl Peroxide Gel 1%5%","slug":"clindamycin-and-benzoyl-peroxide-gel-1-5","indication":"Other","status":"phase_1"},{"name":"GL0034 Dose Level 1","genericName":"GL0034 Dose Level 1","slug":"gl0034-dose-level-1","indication":"Other","status":"phase_2"},{"name":"GL0034 Dose Level 6","genericName":"GL0034 Dose Level 6","slug":"gl0034-dose-level-6","indication":"Other","status":"phase_2"},{"name":"Lac-Hydrin","genericName":"AMMONIUM LACTATE","slug":"ammonium-lactate","indication":"Ichthyosis vulgaris","status":"marketed"},{"name":"Levulan","genericName":"AMINOLEVULINIC ACID","slug":"aminolevulinic-acid","indication":"Actinic keratosis","status":"marketed"},{"name":"MM-II dose I","genericName":"MM-II dose I","slug":"mm-ii-dose-i","indication":"Other","status":"phase_2"},{"name":"MM-II dose III","genericName":"MM-II dose III","slug":"mm-ii-dose-iii","indication":"Other","status":"phase_2"},{"name":"OTX-101 0.05%","genericName":"OTX-101 0.05%","slug":"otx-101-0-05","indication":"Other","status":"phase_2"},{"name":"Placebo0921","genericName":"Placebo0921","slug":"placebo0921","indication":"Other","status":"phase_3"},{"name":"Pregnant women exposed to tildrakizumab","genericName":"Pregnant women exposed to tildrakizumab","slug":"pregnant-women-exposed-to-tildrakizumab","indication":"Other","status":"phase_2"},{"name":"Ref-08-038","genericName":"Ref-08-038","slug":"ref-08-038","indication":"Other","status":"phase_1"},{"name":"Reference001 - Hydrocodone","genericName":"Reference001 - Hydrocodone","slug":"reference001-hydrocodone","indication":"Other","status":"phase_1"},{"name":"Reference001 type I","genericName":"Reference001 type I","slug":"reference001-type-i","indication":"Other","status":"phase_1"},{"name":"Reference001 type II","genericName":"Reference001 type II","slug":"reference001-type-ii","indication":"Other","status":"phase_1"},{"name":"Reference147609","genericName":"Reference147609","slug":"reference147609","indication":"Other","status":"phase_1"},{"name":"Reference147709","genericName":"Reference147709","slug":"reference147709","indication":"Other","status":"phase_1"},{"name":"Reference1613","genericName":"Reference1613","slug":"reference1613","indication":"Other","status":"phase_1"},{"name":"SCD-044_Dose 2","genericName":"SCD-044_Dose 2","slug":"scd-044-dose-2","indication":"Other","status":"phase_2"},{"name":"SCD-044_Dose 3","genericName":"SCD-044_Dose 3","slug":"scd-044-dose-3","indication":"Other","status":"phase_2"},{"name":"SCO-120","genericName":"SCO-120","slug":"sco-120","indication":"Other","status":"phase_1"},{"name":"SPARC-08-038","genericName":"SPARC-08-038","slug":"sparc-08-038","indication":"Other","status":"phase_1"},{"name":"SPARC001 type I","genericName":"SPARC001 type I","slug":"sparc001-type-i","indication":"Other","status":"phase_1"},{"name":"SPARC001 type II","genericName":"SPARC001 type II","slug":"sparc001-type-ii","indication":"Other","status":"phase_1"},{"name":"SPARC001A","genericName":"SPARC001A","slug":"sparc001a","indication":"Other","status":"phase_1"},{"name":"SPARC001B","genericName":"SPARC001B","slug":"sparc001b","indication":"Other","status":"phase_1"},{"name":"SPARC0913","genericName":"SPARC0913","slug":"sparc0913","indication":"Phase 3 clinical trials are ongoing for SPARC0913 in various indications.","status":"phase_3"},{"name":"SPARC1023 II","genericName":"SPARC1023 II","slug":"sparc1023-ii","indication":"Other","status":"phase_1"},{"name":"SPARC1102 I","genericName":"SPARC1102 I","slug":"sparc1102-i","indication":"Other","status":"phase_2"},{"name":"SPARC1102 II","genericName":"SPARC1102 II","slug":"sparc1102-ii","indication":"Other","status":"phase_2"},{"name":"SPARC1103 high dose","genericName":"SPARC1103 high dose","slug":"sparc1103-high-dose","indication":"Other","status":"phase_2"},{"name":"SPARC1104 modified dose regimen III","genericName":"SPARC1104 modified dose regimen III","slug":"sparc1104-modified-dose-regimen-iii","indication":"Other","status":"phase_3"},{"name":"SPARC1203","genericName":"SPARC1203","slug":"sparc1203","indication":"Other","status":"phase_2"},{"name":"SPARC1310 I","genericName":"SPARC1310 I","slug":"sparc1310-i","indication":"Other","status":"phase_2"},{"name":"SPARC1310 III","genericName":"SPARC1310 III","slug":"sparc1310-iii","indication":"Other","status":"phase_2"},{"name":"SPARC1316 Dose 1","genericName":"SPARC1316 Dose 1","slug":"sparc1316-dose-1","indication":"Other","status":"phase_1"},{"name":"SPARC147709","genericName":"SPARC147709","slug":"sparc147709","indication":"Other","status":"phase_1"},{"name":"SPARC1613","genericName":"SPARC1613","slug":"sparc1613","indication":"Other","status":"phase_1"},{"name":"SUNPG1623 I","genericName":"SUNPG1623 I","slug":"sunpg1623-i","indication":"Other","status":"phase_2"},{"name":"SUNPG1623 II","genericName":"SUNPG1623 II","slug":"sunpg1623-ii","indication":"Other","status":"phase_2"},{"name":"SUNPG1623 III","genericName":"SUNPG1623 III","slug":"sunpg1623-iii","indication":"Other","status":"phase_2"},{"name":"Tretinoin cream 0.1%","genericName":"Tretinoin cream 0.1%","slug":"tretinoin-cream-0-1","indication":"Other","status":"phase_2"},{"name":"Trifarotene Cream 0.005%","genericName":"Trifarotene Cream 0.005%","slug":"trifarotene-cream-0-005","indication":"Other","status":"phase_1"},{"name":"matching placebo injections","genericName":"matching placebo injections","slug":"matching-placebo-injections","indication":"Comparing the efficacy of a new drug to a placebo","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":500000000,"percentOfTotal":16.1,"drugCount":8,"colorKey":"immunology","drugs":[{"name":"Sunpg 1622","genericName":"TILDRAKIZUMAB","slug":"tildrakizumab","indication":"Moderate-to-severe plaque psoriasis","status":"marketed","revenue":500000000},{"name":"Desoximetasone Spray 0.25%","genericName":"Desoximetasone Spray 0.25%","slug":"desoximetasone-spray-0-25","indication":"Inflammatory and pruritic dermatoses responsive to topical corticosteroids (e.g., eczema, psoriasis, dermatitis)","status":"marketed"},{"name":"DSXS topical product","genericName":"DSXS topical product","slug":"dsxs-topical-product","indication":"Seborrheic dermatitis","status":"phase_2"},{"name":"TILD","genericName":"TILD","slug":"tild","indication":"Plaque psoriasis","status":"marketed"},{"name":"ADPS topical product","genericName":"ADPS topical product","slug":"adps-topical-product","indication":"Psoriasis","status":"phase_2"},{"name":"Halobetasol Topical Lotion","genericName":"Halobetasol Topical Lotion","slug":"halobetasol-topical-lotion","indication":"Inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses","status":"marketed"},{"name":"ILUMYA","genericName":"TILDRAKIZUMAB-ASMN","slug":"tildrakizumab-asmn","indication":"Plaque psoriasis","status":"marketed"},{"name":"Injections of tildrakizumab","genericName":"Injections of tildrakizumab","slug":"injections-of-tildrakizumab","indication":"Moderate to severe plaque psoriasis","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":8,"colorKey":"cardiovascular","drugs":[{"name":"Dacogen","genericName":"decitabine","slug":"decitabine","indication":"Acute myeloid leukemia, disease","status":"marketed"},{"name":"SPARC1104 modified dose regimen I","genericName":"SPARC1104 modified dose regimen I","slug":"sparc1104-modified-dose-regimen-i","indication":"Non-small cell lung cancer, PD-L1 positive","status":"phase_3"},{"name":"SPARC0912","genericName":"SPARC0912","slug":"sparc0912","indication":"Peripheral T-cell lymphoma (PTCL)","status":"phase_3"},{"name":"Halog","genericName":"HALCINONIDE","slug":"halcinonide","indication":"Atopic dermatitis","status":"marketed"},{"name":"ISV-303","genericName":"ISV-303","slug":"isv-303","indication":"Cancer (specific indication under clinical evaluation in Phase 3)","status":"phase_3"},{"name":"ISV-305","genericName":"ISV-305","slug":"isv-305","indication":"Oncology indication (specific indication not publicly confirmed)","status":"phase_3"},{"name":"Octreoscan","genericName":"PENTETREOTIDE","slug":"pentetreotide","indication":"primary neuroendocrine tumors","status":"marketed"},{"name":"Reference0912","genericName":"Reference0912","slug":"reference0912","indication":"Non-small cell lung cancer, PD-L1 positive","status":"phase_3"}]},{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"neuroscience","drugs":[{"name":"Winlevi","genericName":"CLASCOTERONE","slug":"clascoterone","indication":"Acne vulgaris","status":"marketed"},{"name":"DSXS topical","genericName":"DSXS topical","slug":"dsxs-topical","indication":"Dermatological indication (specific indication not publicly disclosed)","status":"phase_3"},{"name":"Onexton™ Gel","genericName":"Onexton™ Gel","slug":"onexton-gel","indication":"Acne vulgaris","status":"phase_3"},{"name":"Westcort","genericName":"HYDROCORTISONE VALERATE","slug":"hydrocortisone-valerate","indication":"Corticosteroid-responsive dermatoses","status":"marketed"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"respiratory","drugs":[{"name":"DSXS","genericName":"DSXS","slug":"dsxs","indication":"Type 2 diabetes","status":"phase_3"},{"name":"SDN-037","genericName":"SDN-037","slug":"sdn-037","indication":"Type 2 diabetes","status":"phase_3"},{"name":"SPARC0921","genericName":"SPARC0921","slug":"sparc0921","indication":"Type 2 diabetes","status":"phase_3"},{"name":"SPIL1033","genericName":"SPIL1033","slug":"spil1033","indication":"Type 2 diabetes","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"infectious","drugs":[{"name":"Naftifine Hydrochloride Cream 2%","genericName":"Naftifine Hydrochloride Cream 2%","slug":"naftifine-hydrochloride-cream-2","indication":"Tinea pedis (athlete's foot)","status":"phase_3"},{"name":"Qualaquin","genericName":"QUININE","slug":"quinine","indication":"Chloroquine Resistant Plasmodium Falciparum Malaria","status":"marketed"},{"name":"Zero-dose","genericName":"Zero-dose","slug":"zero-dose","indication":"COVID-19 prevention","status":"phase_3"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"ophthalmology","drugs":[{"name":"PART 1: Double-blind Placebo-controlled","genericName":"PART 1: Double-blind Placebo-controlled","slug":"part-1-double-blind-placebo-controlled","indication":"Major depressive disorder","status":"phase_3"},{"name":"SAPHRIS","genericName":"SAPHRIS","slug":"saphris","indication":"Schizophrenia","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"rare","drugs":[{"name":"Brinzolamide ophthalmic suspension","genericName":"Brinzolamide ophthalmic suspension","slug":"brinzolamide-ophthalmic-suspension","indication":"Elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma","status":"phase_3"}]},{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"metabolic","drugs":[{"name":"OTX-101 0.09%","genericName":"OTX-101 0.09%","slug":"otx-101-0-09","indication":"Treatment of dry eye disease","status":"phase_3"}]}],"pipeline":[{"name":"Leqselvi","genericName":"DEURUXOLITINIB","slug":"deuruxolitinib","phase":"marketed","mechanism":"Deuruxolitinib inhibits JAK1, JAK2, and TYK2, modulating cytokine and growth factor signaling involved in hematopoiesis and immune function.","indications":["severe alopecia areata"],"catalyst":""},{"name":"Sunpg 1622","genericName":"TILDRAKIZUMAB","slug":"tildrakizumab","phase":"marketed","mechanism":"Tildrakizumab blocks the action of Interleukin-23, a protein that promotes inflammation.","indications":["Moderate-to-severe plaque psoriasis"],"catalyst":""},{"name":"Dacogen","genericName":"decitabine","slug":"decitabine","phase":"marketed","mechanism":"Dacogen works by inhibiting the enzyme that adds methyl groups to DNA, which helps to restore normal gene function in cancer cells.","indications":["Acute myeloid leukemia, disease","Myelodysplastic syndrome"],"catalyst":""},{"name":"Winlevi","genericName":"CLASCOTERONE","slug":"clascoterone","phase":"marketed","mechanism":"Winlevi works by blocking the androgen receptor, a protein that helps regulate hormones in the body.","indications":["Acne vulgaris"],"catalyst":""},{"name":"CABTREO Topical Gel","genericName":"CABTREO Topical Gel","slug":"cabtreo-topical-gel","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Ovide (malathion) lotion 0.05%","genericName":"Ovide (malathion) lotion 0.05%","slug":"ovide-malathion-lotion-0-05","phase":"phase_3","mechanism":"Ovide (malathion) lotion works by killing lice and their eggs on the scalp.","indications":["Treatment of head lice infestations"],"catalyst":""},{"name":"Oxiconazole Nitrate Cream 1%","genericName":"Oxiconazole Nitrate Cream 1%","slug":"oxiconazole-nitrate-cream-1","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Protopic - Tacrolimus 0.1%","genericName":"Protopic - Tacrolimus 0.1%","slug":"protopic-tacrolimus-0-1","phase":"phase_1","mechanism":"Tacrolimus inhibits calcineurin, blocking T-cell activation and preventing the release of inflammatory cytokines in the skin.","indications":[],"catalyst":""},{"name":"SPARC1102 III","genericName":"SPARC1102 III","slug":"sparc1102-iii","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SUNPG1623 IV","genericName":"SUNPG1623 IV","slug":"sunpg1623-iv","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Aldara - Imiquimod 5%","genericName":"Aldara - Imiquimod 5%","slug":"aldara-imiquimod-5","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"CLPG Topical Gel 1%","genericName":"CLPG Topical Gel 1%","slug":"clpg-topical-gel-1","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Clindamycin Phosphate RLD","genericName":"Clindamycin Phosphate RLD","slug":"clindamycin-phosphate-rld","phase":"phase_1","mechanism":"Clindamycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation.","indications":[],"catalyst":""},{"name":"DSXS topical","genericName":"DSXS topical","slug":"dsxs-topical","phase":"phase_3","mechanism":"DSXS is a topical formulation designed to deliver active pharmaceutical ingredients to skin lesions or dermatological conditions through enhanced penetration.","indications":["Dermatological indication (specific indication not publicly disclosed)"],"catalyst":""},{"name":"Desoximetasone 0.05% once daily","genericName":"Desoximetasone 0.05% once daily","slug":"desoximetasone-0-05-once-daily","phase":"phase_2","mechanism":"Desoximetasone binds to glucocorticoid receptors in skin cells to suppress inflammatory mediators and immune cell activity.","indications":[],"catalyst":""},{"name":"Desoximetasone 0.05% twice daily","genericName":"Desoximetasone 0.05% twice daily","slug":"desoximetasone-0-05-twice-daily","phase":"phase_2","mechanism":"Desoximetasone binds to glucocorticoid receptors in skin cells, reducing inflammation by suppressing immune cell activity and inflammatory mediator release.","indications":[],"catalyst":""},{"name":"Desoximetasone 0.25% once daily","genericName":"Desoximetasone 0.25% once daily","slug":"desoximetasone-0-25-once-daily","phase":"phase_2","mechanism":"Desoximetasone is a corticosteroid that binds to glucocorticoid receptors to suppress inflammatory and immune responses in the skin.","indications":[],"catalyst":""},{"name":"Desoximetasone Spray 0.25%","genericName":"Desoximetasone Spray 0.25%","slug":"desoximetasone-spray-0-25","phase":"marketed","mechanism":"Desoximetasone is a topical corticosteroid that suppresses inflammatory and immune responses in the skin by binding to glucocorticoid receptors.","indications":["Inflammatory and pruritic dermatoses responsive to topical corticosteroids (e.g., eczema, psoriasis, dermatitis)"],"catalyst":""},{"name":"Imiquimod 5% manufactured by Taro","genericName":"Imiquimod 5% manufactured by Taro","slug":"imiquimod-5-manufactured-by-taro","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Imiquimod Topical Cream 3.75%","genericName":"Imiquimod Topical Cream 3.75%","slug":"imiquimod-topical-cream-3-75","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Malathion gel 0.5%","genericName":"Malathion gel 0.5%","slug":"malathion-gel-0-5","phase":"phase_3","mechanism":"Malathion is an organophosphate insecticide that inhibits acetylcholinesterase, causing accumulation of acetylcholine and paralysis of parasites.","indications":["Head lice infestation (pediculosis capitis)","Scabies (Sarcoptes scabiei infestation)"],"catalyst":""},{"name":"Malathion lotion 0.5%","genericName":"Malathion lotion 0.5%","slug":"malathion-lotion-0-5","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"NVXT Solution","genericName":"NVXT Solution","slug":"nvxt-solution","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Naftifine Hydrochloride Cream 2%","genericName":"Naftifine Hydrochloride Cream 2%","slug":"naftifine-hydrochloride-cream-2","phase":"phase_3","mechanism":"Naftifine is a fungistatic agent that inhibits fungal sterol synthesis by blocking squalene epoxidase, disrupting the fungal cell membrane.","indications":["Tinea pedis (athlete's foot)","Tinea cruris (jock itch)","Tinea corporis (ringworm)","Other dermatophyte infections"],"catalyst":""},{"name":"Naftin® Gel 2%","genericName":"Naftin® Gel 2%","slug":"naftin-gel-2","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Oxymetazoline hydrochloride Cream, 1%","genericName":"Oxymetazoline hydrochloride Cream, 1%","slug":"oxymetazoline-hydrochloride-cream-1","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"RETIN-A® Cream","genericName":"RETIN-A® Cream","slug":"retin-a-cream","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Ruxolitinib Topical Cream 1.5%","genericName":"Ruxolitinib Topical Cream 1.5%","slug":"ruxolitinib-topical-cream-1-5","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SPARC1104 modified dose regimen I","genericName":"SPARC1104 modified dose regimen I","slug":"sparc1104-modified-dose-regimen-i","phase":"phase_3","mechanism":"SPARC1104 modified dose regimen I is a drug that targets the PD-1/PD-L1 pathway.","indications":["Non-small cell lung cancer, PD-L1 positive"],"catalyst":""},{"name":"Tacrolimus 0.1% manufactured by Taro","genericName":"Tacrolimus 0.1% manufactured by Taro","slug":"tacrolimus-0-1-manufactured-by-taro","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Bactroban® Cream","genericName":"Bactroban® Cream","slug":"bactroban-cream","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Butenafine Hydrochloride Cream, 1%","genericName":"Butenafine Hydrochloride Cream, 1%","slug":"butenafine-hydrochloride-cream-1","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"DPSG 7.5%","genericName":"DPSG 7.5%","slug":"dpsg-7-5","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"DSXS","genericName":"DSXS","slug":"dsxs","phase":"phase_3","mechanism":"DSXS is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"DSXS topical product","genericName":"DSXS topical product","slug":"dsxs-topical-product","phase":"phase_2","mechanism":"DSXS topical product is a corticosteroid that reduces inflammation and itching by suppressing the immune system.","indications":["Seborrheic dermatitis","Psoriasis"],"catalyst":""},{"name":"DSXS1411","genericName":"DSXS1411","slug":"dsxs1411","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Duac® Topical Gel","genericName":"Duac® Topical Gel","slug":"duac-topical-gel","phase":"phase_1","mechanism":"Combines clindamycin's antibacterial action against Cutibacterium acnes with benzoyl peroxide's antimicrobial and keratolytic effects.","indications":[],"catalyst":""},{"name":"GL0034 Dose Level 2","genericName":"GL0034 Dose Level 2","slug":"gl0034-dose-level-2","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"GL0034 Dose Level 4","genericName":"GL0034 Dose Level 4","slug":"gl0034-dose-level-4","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Lotrimin Ultra®","genericName":"Lotrimin Ultra®","slug":"lotrimin-ultra","phase":"marketed","mechanism":"Lotrimin Ultra contains butenafine, an allylamine antifungal that disrupts fungal cell membrane synthesis by inhibiting squalene epoxidase.","indications":["Tinea pedis (athlete's foot)","Tinea cruris (jock itch)","Tinea corporis (ringworm)","Tinea versicolor"],"catalyst":""},{"name":"Metronidazole Topical Gel 1%","genericName":"Metronidazole Topical Gel 1%","slug":"metronidazole-topical-gel-1","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"NVXT topical","genericName":"NVXT topical","slug":"nvxt-topical","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Onexton™ Gel","genericName":"Onexton™ Gel","slug":"onexton-gel","phase":"phase_3","mechanism":"Onexton is a topical combination gel containing clindamycin and benzoyl peroxide that reduces acne by killing bacteria and decreasing sebum production.","indications":["Acne vulgaris"],"catalyst":""},{"name":"Permethrin 1% rinse","genericName":"Permethrin 1% rinse","slug":"permethrin-1-rinse","phase":"phase_3","mechanism":"Permethrin 1% rinse works by killing or repelling insects and other arthropods through its insecticidal properties.","indications":["Treatment and prevention of head lice infestations","Treatment and prevention of scabies infestations"],"catalyst":""},{"name":"Placebo topical cream","genericName":"Placebo topical cream","slug":"placebo-topical-cream","phase":"marketed","mechanism":"A placebo topical cream contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect.","indications":[],"catalyst":""},{"name":"Qualaquin","genericName":"QUININE","slug":"quinine","phase":"marketed","mechanism":"Sodium channel alpha subunits; brain (Types I, II, III)","indications":["Chloroquine Resistant Plasmodium Falciparum Malaria","Falciparum malaria"],"catalyst":""},{"name":"SCD-044_Dose 1","genericName":"SCD-044_Dose 1","slug":"scd-044-dose-1","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SPARC0912","genericName":"SPARC0912","slug":"sparc0912","phase":"phase_3","mechanism":"SPARC0912 is a selective inhibitor of histone deacetylase (HDAC) that promotes acetylation of histones and non-histone proteins to modulate gene expression and induce anti-tumor effects.","indications":["Peripheral T-cell lymphoma (PTCL)","Cutaneous T-cell lymphoma (CTCL)"],"catalyst":""},{"name":"SPARC1023 I","genericName":"SPARC1023 I","slug":"sparc1023-i","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SPARC1028","genericName":"SPARC1028","slug":"sparc1028","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SPARC1104 modified dose regimen II","genericName":"SPARC1104 modified dose regimen II","slug":"sparc1104-modified-dose-regimen-ii","phase":"phase_3","mechanism":"SPARC1104 is a modified dose regimen of an undisclosed drug, but it is likely a small molecule targeting a specific molecular pathway.","indications":["Undisclosed indication"],"catalyst":""},{"name":"SPARC1310 II","genericName":"SPARC1310 II","slug":"sparc1310-ii","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SPARC147609","genericName":"SPARC147609","slug":"sparc147609","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"TA103","genericName":"TA103","slug":"ta103","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"TILD","genericName":"TILD","slug":"tild","phase":"marketed","mechanism":"Tild is a small molecule that works by interacting with a specific target in the body.","indications":["Plaque psoriasis"],"catalyst":""},{"name":"Topical TA-102 D","genericName":"Topical TA-102 D","slug":"topical-ta-102-d","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Tretinoin Gel Microsphere, 0.04%","genericName":"Tretinoin Gel Microsphere, 0.04%","slug":"tretinoin-gel-microsphere-0-04","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Tretinoin Gel Microsphere, 0.1%","genericName":"Tretinoin Gel Microsphere, 0.1%","slug":"tretinoin-gel-microsphere-0-1","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Zero-dose","genericName":"Zero-dose","slug":"zero-dose","phase":"phase_3","mechanism":"Zero-dose is a vaccine candidate that uses a novel approach to stimulate an immune response without the need for a traditional vaccine dose.","indications":["COVID-19 prevention"],"catalyst":""},{"name":"abiraterone acetate with Methylprednisolone","genericName":"abiraterone acetate with Methylprednisolone","slug":"abiraterone-acetate-with-methylprednisolone","phase":"phase_2","mechanism":"Abiraterone acetate blocks CYP17A1 enzyme to inhibit androgen production, while methylprednisolone provides corticosteroid replacement and anti-inflammatory effects.","indications":[],"catalyst":""},{"name":"ADPS topical product","genericName":"ADPS topical product","slug":"adps-topical-product","phase":"phase_2","mechanism":"ADPS topical product is a small molecule that targets the skin to treat various conditions.","indications":["Psoriasis"],"catalyst":""},{"name":"Azelaic Acid 15% topical gel","genericName":"Azelaic Acid 15% topical gel","slug":"azelaic-acid-15-topical-gel","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BenzaClin® Topical Gel","genericName":"BenzaClin® Topical Gel","slug":"benzaclin-topical-gel","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Brinzolamide ophthalmic suspension","genericName":"Brinzolamide ophthalmic suspension","slug":"brinzolamide-ophthalmic-suspension","phase":"phase_3","mechanism":"Brinzolamide is a carbonic anhydrase inhibitor that reduces aqueous humor production in the eye, thereby lowering intraocular pressure.","indications":["Elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma"],"catalyst":""},{"name":"Bromday™","genericName":"Bromday™","slug":"bromday","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Butenafine cream 1% manufactured by Taro","genericName":"Butenafine cream 1% manufactured by Taro","slug":"butenafine-cream-1-manufactured-by-taro","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Clindamycin and Benzoyl Peroxide Gel 1%5%","genericName":"Clindamycin and Benzoyl Peroxide Gel 1%5%","slug":"clindamycin-and-benzoyl-peroxide-gel-1-5","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"GL0034 Dose Level 1","genericName":"GL0034 Dose Level 1","slug":"gl0034-dose-level-1","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"GL0034 Dose Level 6","genericName":"GL0034 Dose Level 6","slug":"gl0034-dose-level-6","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Halobetasol Topical Lotion","genericName":"Halobetasol Topical Lotion","slug":"halobetasol-topical-lotion","phase":"marketed","mechanism":"Halobetasol is a potent topical corticosteroid that suppresses inflammatory and immune responses in the skin by binding to glucocorticoid receptors.","indications":["Inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses","Severe dermatitis, psoriasis, and lichen planus (topical)"],"catalyst":""},{"name":"Halog","genericName":"HALCINONIDE","slug":"halcinonide","phase":"marketed","mechanism":"Glucocorticoid receptor","indications":["Atopic dermatitis","Contact dermatitis","Discoid lupus erythematosus","Eruption of skin","Granuloma annulare"],"catalyst":""},{"name":"ILUMYA","genericName":"TILDRAKIZUMAB-ASMN","slug":"tildrakizumab-asmn","phase":"marketed","mechanism":"Interleukin-23","indications":["Plaque psoriasis"],"catalyst":""},{"name":"ISV-303","genericName":"ISV-303","slug":"isv-303","phase":"phase_3","mechanism":"ISV-303 is an investigational immunotherapy designed to enhance anti-tumor immune responses through modulation of the immune checkpoint pathway.","indications":["Cancer (specific indication under clinical evaluation in Phase 3)"],"catalyst":""},{"name":"ISV-305","genericName":"ISV-305","slug":"isv-305","phase":"phase_3","mechanism":"ISV-305 is an investigational immunotherapy designed to enhance anti-tumor immune responses through modulation of the immune checkpoint pathway.","indications":["Oncology indication (specific indication not publicly confirmed)"],"catalyst":""},{"name":"Injections of tildrakizumab","genericName":"Injections of tildrakizumab","slug":"injections-of-tildrakizumab","phase":"marketed","mechanism":"Tildrakizumab is a monoclonal antibody that selectively blocks interleukin-23 (IL-23) to reduce inflammatory immune responses in the skin.","indications":["Moderate to severe plaque psoriasis","Psoriatic arthritis"],"catalyst":""},{"name":"Lac-Hydrin","genericName":"AMMONIUM LACTATE","slug":"ammonium-lactate","phase":"marketed","mechanism":"Small molecule","indications":["Ichthyosis vulgaris","Xerosis"],"catalyst":""},{"name":"Levulan","genericName":"AMINOLEVULINIC ACID","slug":"aminolevulinic-acid","phase":"marketed","mechanism":"Levulan accumulates in abnormal skin cells, allowing for visualization and treatment.","indications":["Actinic keratosis","Fluorescent stain","Non-Hyperkeratotic Actinic Keratoses"],"catalyst":""},{"name":"MM-II dose I","genericName":"MM-II dose I","slug":"mm-ii-dose-i","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"MM-II dose III","genericName":"MM-II dose III","slug":"mm-ii-dose-iii","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"OTX-101 0.05%","genericName":"OTX-101 0.05%","slug":"otx-101-0-05","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"OTX-101 0.09%","genericName":"OTX-101 0.09%","slug":"otx-101-0-09","phase":"phase_3","mechanism":"OTX-101 is a topical ophthalmic solution used to treat dry eye disease.","indications":["Treatment of dry eye disease"],"catalyst":""},{"name":"Octreoscan","genericName":"PENTETREOTIDE","slug":"pentetreotide","phase":"marketed","mechanism":"Recombinant protein","indications":["primary neuroendocrine tumors","metastatic neuroendocrine tumors"],"catalyst":""},{"name":"PART 1: Double-blind Placebo-controlled","genericName":"PART 1: Double-blind Placebo-controlled","slug":"part-1-double-blind-placebo-controlled","phase":"phase_3","mechanism":"This drug is a selective serotonin reuptake inhibitor.","indications":["Major depressive disorder","Generalized anxiety disorder"],"catalyst":""},{"name":"Placebo0921","genericName":"Placebo0921","slug":"placebo0921","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Pregnant women exposed to tildrakizumab","genericName":"Pregnant women exposed to tildrakizumab","slug":"pregnant-women-exposed-to-tildrakizumab","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Ref-08-038","genericName":"Ref-08-038","slug":"ref-08-038","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Reference001 - Hydrocodone","genericName":"Reference001 - Hydrocodone","slug":"reference001-hydrocodone","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Reference001 type I","genericName":"Reference001 type I","slug":"reference001-type-i","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Reference001 type II","genericName":"Reference001 type II","slug":"reference001-type-ii","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Reference0912","genericName":"Reference0912","slug":"reference0912","phase":"phase_3","mechanism":"Reference0912 is a drug that targets the PD-1 receptor.","indications":["Non-small cell lung cancer, PD-L1 positive"],"catalyst":""},{"name":"Reference147609","genericName":"Reference147609","slug":"reference147609","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Reference147709","genericName":"Reference147709","slug":"reference147709","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Reference1613","genericName":"Reference1613","slug":"reference1613","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SAPHRIS","genericName":"SAPHRIS","slug":"saphris","phase":"marketed","mechanism":"SAPHRIS (asenapine) is an atypical antipsychotic that blocks dopamine and serotonin receptors in the brain to reduce psychotic symptoms and mood disturbances.","indications":["Schizophrenia","Bipolar I disorder (acute manic or mixed episodes)"],"catalyst":""},{"name":"SCD-044_Dose 2","genericName":"SCD-044_Dose 2","slug":"scd-044-dose-2","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SCD-044_Dose 3","genericName":"SCD-044_Dose 3","slug":"scd-044-dose-3","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SCO-120","genericName":"SCO-120","slug":"sco-120","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SDN-037","genericName":"SDN-037","slug":"sdn-037","phase":"phase_3","mechanism":"SDN-037 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"SPARC-08-038","genericName":"SPARC-08-038","slug":"sparc-08-038","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SPARC001 type I","genericName":"SPARC001 type I","slug":"sparc001-type-i","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SPARC001 type II","genericName":"SPARC001 type II","slug":"sparc001-type-ii","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SPARC001A","genericName":"SPARC001A","slug":"sparc001a","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SPARC001B","genericName":"SPARC001B","slug":"sparc001b","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SPARC0913","genericName":"SPARC0913","slug":"sparc0913","phase":"phase_3","mechanism":"SPARC0913 is a small molecule that targets the molecular target.","indications":["Phase 3 clinical trials are ongoing for SPARC0913 in various indications."],"catalyst":""},{"name":"SPARC0921","genericName":"SPARC0921","slug":"sparc0921","phase":"phase_3","mechanism":"SPARC0921 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"SPARC1023 II","genericName":"SPARC1023 II","slug":"sparc1023-ii","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SPARC1102 I","genericName":"SPARC1102 I","slug":"sparc1102-i","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SPARC1102 II","genericName":"SPARC1102 II","slug":"sparc1102-ii","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SPARC1103 high dose","genericName":"SPARC1103 high dose","slug":"sparc1103-high-dose","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SPARC1104 modified dose regimen III","genericName":"SPARC1104 modified dose regimen III","slug":"sparc1104-modified-dose-regimen-iii","phase":"phase_3","mechanism":"SPARC1104 is a modified dose regimen of an undisclosed compound, details of which are not publicly available.","indications":[],"catalyst":""},{"name":"SPARC1203","genericName":"SPARC1203","slug":"sparc1203","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SPARC1310 I","genericName":"SPARC1310 I","slug":"sparc1310-i","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SPARC1310 III","genericName":"SPARC1310 III","slug":"sparc1310-iii","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SPARC1316 Dose 1","genericName":"SPARC1316 Dose 1","slug":"sparc1316-dose-1","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SPARC147709","genericName":"SPARC147709","slug":"sparc147709","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SPARC1613","genericName":"SPARC1613","slug":"sparc1613","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SPIL1033","genericName":"SPIL1033","slug":"spil1033","phase":"phase_3","mechanism":"SPIL1033 is a small molecule drug that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"SUNPG1623 I","genericName":"SUNPG1623 I","slug":"sunpg1623-i","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SUNPG1623 II","genericName":"SUNPG1623 II","slug":"sunpg1623-ii","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SUNPG1623 III","genericName":"SUNPG1623 III","slug":"sunpg1623-iii","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Tretinoin cream 0.1%","genericName":"Tretinoin cream 0.1%","slug":"tretinoin-cream-0-1","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Trifarotene Cream 0.005%","genericName":"Trifarotene Cream 0.005%","slug":"trifarotene-cream-0-005","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Westcort","genericName":"HYDROCORTISONE VALERATE","slug":"hydrocortisone-valerate","phase":"marketed","mechanism":"Glucocorticoid receptor","indications":["Corticosteroid-responsive dermatoses"],"catalyst":""},{"name":"matching placebo injections","genericName":"matching placebo injections","slug":"matching-placebo-injections","phase":"phase_3","mechanism":"Matching placebo injections are used to compare the efficacy of a new drug to a placebo.","indications":["Comparing the efficacy of a new drug to a placebo"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":124,"phaseCounts":{"marketed":19,"phase_1":48,"phase_3":24,"phase_2":33},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}